Learn About Hypogonadotropic Hypogonadism

What is the definition of Hypogonadotropic Hypogonadism?

Hypogonadism is a condition in which the male testes or the female ovaries produce little or no sex hormones.

Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothalamus.

What are the alternative names for Hypogonadotropic Hypogonadism?

Gonadotropin deficiency; Secondary hypogonadism

What are the causes of Hypogonadotropic Hypogonadism?

HH is caused by a lack of hormones that normally stimulate the ovaries or testes. These hormones include:

  • Gonadotropin-releasing hormone (GnRH)
  • Follicle stimulating hormone (FSH)
  • Luteinizing hormone (LH)

Normally:

  • The hypothalamus in the brain releases GnRH.
  • This hormone stimulates the pituitary gland to release FSH and LH.
  • These hormones tell the female ovaries or the male testes to release hormones that lead to normal sexual development in puberty, normal menstrual cycles, estrogen levels and fertility in adult women, and normal testosterone production and sperm production in adult men.
  • Any change in this hormone release chain causes a lack of sex hormones. This prevents normal sexual maturity in children and normal function of the testicles or ovaries in adults.

There are several causes of HH:

  • Damage to the pituitary gland or hypothalamus from surgery, injury, tumor, infection, or radiation
  • Genetic defects
  • High doses or long-term use of opioid or steroid (glucocorticoid) medicines
  • High prolactin level (a different hormone released by the pituitary)
  • Severe stress
  • Nutritional problems (both rapid weight gain or weight loss)
  • Long-term (chronic) medical diseases, including chronic inflammation or infections
  • Drug use, such as heroin or use or abuse of prescription opioid medicines
  • Certain medical conditions, such as iron overload

Kallmann syndrome is an inherited form of HH. Some people with this condition also lose their sense of smell (anosmia).

What are the symptoms of Hypogonadotropic Hypogonadism?

Children:

  • Lack of growth and sexual development at the standard age for puberty (development may be very late or incomplete)
  • In girls, a lack of breast development and menstrual periods
  • In boys, no development of sex characteristics, such as enlargement of the testes and penis, deepening of the voice, and facial hair
  • Inability to smell (in some cases)
  • Short stature (in some cases)

Adults:

  • Loss of interest in sex (libido) in men
  • Loss of menstrual periods (amenorrhea) in women
  • Decreased energy and interest in activities
  • Loss of muscle mass in men
  • Weight gain
  • Mood changes
  • Infertility
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hypogonadotropic Hypogonadism?

Treatment depends on the source of the problem, but may involve:

  • Injections of testosterone (in males)
  • Slow-release testosterone skin patch (in males)
  • Testosterone gels (in males)
  • Estrogen and progesterone pills or skin patches (in females)
  • GnRH injections
  • HCG injections
Who are the top Hypogonadotropic Hypogonadism Local Doctors?
Elite in Hypogonadotropic Hypogonadism
Endocrinology
Elite in Hypogonadotropic Hypogonadism
Endocrinology
221 Longwood Ave Rfb 2, Bwh Endocrinology Diabetes And Hypertension, 
Boston, MA 
Languages Spoken:
English

Ursula Kaiser is an Endocrinologist in Boston, Massachusetts. Dr. Kaiser is rated as an Elite provider by MediFind in the treatment of Hypogonadotropic Hypogonadism. Her top areas of expertise are Precocious Puberty, Hypogonadotropic Hypogonadism, Hypogonadism, Pituitary Tumor, and Orchiectomy.

Elite in Hypogonadotropic Hypogonadism
Elite in Hypogonadotropic Hypogonadism

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Stephanie Seminara is an Endocrinologist in Boston, Massachusetts. Dr. Seminara is rated as an Elite provider by MediFind in the treatment of Hypogonadotropic Hypogonadism. Her top areas of expertise are Hypogonadotropic Hypogonadism, Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome, and Hormone Replacement Therapy (HRT). Dr. Seminara is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hypogonadotropic Hypogonadism
Endocrinology
Elite in Hypogonadotropic Hypogonadism
Endocrinology
Massachusetts General Hospital, 55 Fruit St. Rev.bhe 5, 
Boston, MA 
Languages Spoken:
English

Nelly Pitteloud is an Endocrinologist in Boston, Massachusetts. Dr. Pitteloud is rated as an Elite provider by MediFind in the treatment of Hypogonadotropic Hypogonadism. Her top areas of expertise are Hypogonadotropic Hypogonadism, Hypogonadism, Kallmann Syndrome, Hormone Replacement Therapy (HRT), and Gastric Bypass.

What is the outlook (prognosis) for Hypogonadotropic Hypogonadism?

The right hormone treatment will cause puberty to start in children and may restore fertility in adults. If the condition begins after puberty or in adulthood, symptoms will often improve with treatment.

What are the possible complications of Hypogonadotropic Hypogonadism?

Health problems that may result from HH include:

  • Delayed puberty
  • Early menopause (in females)
  • Infertility
  • Low bone density and fractures later in life
  • Low self-esteem due to late start of puberty (emotional support may be helpful)
  • Sexual problems, such as low libido
When should I contact a medical professional for Hypogonadotropic Hypogonadism?

Contact your provider if:

  • Your child does not start puberty at the appropriate time.
  • You are a woman under age 40 and your menstrual cycles stop.
  • You have lost armpit or pubic hair.
  • You are a man and you have decreased interest in sex.
What are the latest Hypogonadotropic Hypogonadism Clinical Trials?
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

Summary: The goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in men and women with idiopathic hypogonadotropic hypogonadism (IHH). The investigators are also examining whether kisspeptin can help women release eggs from their ovaries. Kisspeptin will be administered SC for two weeks in a pulsatile fashion. Ultrasound m...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Opioid Antagonism in Hypogonadotropic Hypogonadism

Summary: The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).

Who are the sources who wrote this article ?

Published Date: July 30, 2023
Published By: Sandeep K. Dhaliwal, MD, board-certified in Diabetes, Endocrinology, and Metabolism, Springfield, VA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364 pubmed.ncbi.nlm.nih.gov/29562364/.

Styne DM. Physiology and disorders of puberty. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020:chap 26.

White PC. Sexual development. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 220.